Form 8-K - Current report:
SEC Accession No. 0001140361-26-015801
Filing Date
2026-04-21
Accepted
2026-04-21 07:00:40
Documents
13
Period of Report
2026-04-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20071051_8k.htm   iXBRL 8-K 40625
2 EXHIBIT 99.1 ef20071051_ex99-1.htm EX-99.1 29547
6 image00001.jpg GRAPHIC 3534
  Complete submission text file 0001140361-26-015801.txt   214904

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20260421.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20260421_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20260421_pre.xml EX-101.PRE 16038
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20071051_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 26876704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)